Tandem Diabetes Care to Webcast Investor & Analyst Day on September 25, 2018
12 September 2018 - 11:00PM
Business Wire
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device
company and manufacturer of the only touchscreen insulin pumps with
continuous glucose monitoring integration, today announced it will
host an Institutional Investor and Analyst Day from 8:30am to
1:00pm Pacific Time on Tuesday, September 25, 2018 in San Diego,
California. The program will include presentations regarding the
Company’s longer-term vision, product pipeline, and international
expansion. In addition, presentations will be given by clinical and
industry experts on the subject of automated insulin delivery
(AID). The Company will also host a healthcare provider and patient
panel, provide product demonstrations, and will offer tours of its
new manufacturing facility.
Institutional investors and analysts are invited to attend live
and are encouraged to register in advance at
http://investor.tandemdiabetes.com/institutional-investor-analyst-day.
A live webcast and archived recording of the presentations by
members of management and clinical and industry thought leaders
will be accessible on Tandem Diabetes Care’s Investor Center
website located at http://investor.tandemdiabetes.com in the
“Events & Presentations” section. The remainder of the event
will not be webcast. An archive of the recorded portion of the
event will be available for 30 days.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical
device company dedicated to improving the lives of people with
diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach
to the design, development and commercialization of products for
people with diabetes who use insulin. Tandem manufactures and sells
the t:slim X2™ Insulin Pump with Basal-IQ™ technology. The t:slim
X2 Pump is capable of remote feature updates using a personal
computer and is the only automated insulin delivery device approved
for children as young as 6 years old. Tandem is based in San Diego,
California.
Tandem Diabetes Care is a registered trademark, and t:slim X2
and Basal-IQ are trademarks of Tandem Diabetes Care, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180912005387/en/
For Tandem Diabetes Care, Inc.Media Contact:Steve
Sabicer, 714-907-6264ssabicer@thesabicergroup.comorInvestor
Contact:Susan Morrison, 858-366-6900
x7005ir@tandemdiabetes.com
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From Apr 2024 to May 2024
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From May 2023 to May 2024